{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-24-007235","form_type":"8-K","ticker":"NXL","cik":"0001527352","company_name":"Nexalin Technology, Inc.","filed_at":"2024-11-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.689134+00:00","generated_at":"2026-05-30T06:55:17.347118+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Nexalin regains compliance with Nasdaq minimum bid price rule","bullets":["Received notice from Nasdaq on Oct. 31, 2024, confirming compliance with Rule 5550(a)(2).","Regaining compliance removes the risk of delisting from the Nasdaq exchange.","CEO Mark White highlighted the milestone for shareholder value and clinical progress.","Company trades under symbols NXL and NXLIW on Nasdaq."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-24-007235","json":"https://secwatch.observer/filing/0001829126-24-007235.json","markdown":"https://secwatch.observer/filing/0001829126-24-007235.md","text":"https://secwatch.observer/filing/0001829126-24-007235.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527352/000182912624007235/0001829126-24-007235-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527352/000182912624007235/nexalintec_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T06:55:17.347118+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}